Article
Chemoresponse to docetaxel correlates with expression of the survivin splicing variants in patients with gastric cancer.
Hepato-gastroenterology - 1 Jan 2000
Meng Hua, Tanigawa Nobuhiko, Hao Chun-Yi, Dai De-Jian, Lu Cai-De, Ji Jia-Fu
Abstract excerpt
BACKGROUND/AIMS: Survivin, a potential predictive marker to chemotherapeutic drugs, reduces the susceptibility of tumor cells to proapoptotic stimuli, thereby promoting tumor cell survival during tumor treatment with anticancer agents. In the present study, we examined the correlation between drug-response and expression of survivin in gastric cancer. METHODOLOGY: Drug-response was performed by histoculture...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.